Sage Therapeutics, Inc.
Neuroactive steroid formulations and methods of treating CNS disorders

Last updated:

Abstract:

Formulations of comprising a neuroactive steroid, e.g., allopregnanolone; and optionally a cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., CAPTISOL.RTM.; and methods of use in treating CNS disorders.

Status:
Grant
Type:

Utility

Filling date:

26 Apr 2019

Issue date:

30 Aug 2022